Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An allelotype of papillary thyroid cancer

J A Califano1, M M Johns, W H Westra

  • 1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, MD 21205, USA.

International Journal of Cancer
|December 20, 1996
PubMed
Summary

This study identified chromosomal regions with significant loss of heterozygosity/allelic imbalance in papillary thyroid cancer. These findings suggest potential tumor-suppressor gene locations on chromosomes 4q, 5p, and 7p.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

HPV status, like politics, is local-evaluating p16 staining and a new staging system in a Dutch cohort of oropharynx cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.

Journal of dental research·2018
Same author

Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Human papillomavirus tumour status is not associated with a positive depression screen for patients with oropharyngeal cancer.

The Journal of laryngology and otology·2017
Same author

Patient-derived xenografts as tools in pharmaceutical development.

Clinical pharmacology and therapeutics·2016

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Papillary thyroid carcinoma is the most common thyroid cancer, yet specific chromosomal deletions remain unidentified.
  • Previous allelic loss studies have not pinpointed chromosomal deletion areas in this cancer type.

Purpose of the Study:

  • To investigate chromosomal loss and allelic imbalance in papillary thyroid carcinoma.
  • To identify specific chromosomal arms harboring potential tumor-suppressor genes.

Main Methods:

  • Examined 30 papillary thyroid carcinoma samples.
  • Utilized microsatellite markers to assess loss of heterozygosity/allelic imbalance (LOH/AI) across all autosomal arms.

Main Results:

  • Fifteen out of 30 tumors (50%) showed LOH/AI at one or more loci.

Related Experiment Videos

  • Frequent LOH/AI was observed on chromosomal arms 4q, 5p, 7p, and 11p.
  • An average of 1.1 chromosomal arms with LOH/AI per tumor was detected.

    • Conclusions:

    • Chromosomal arms 4q, 5p, and 7p exhibit significant LOH/AI in papillary thyroid cancer.
    • These regions likely contain critical tumor-suppressor genes involved in thyroid cancer development.
    • Further research into these loci may reveal new therapeutic targets.